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Abstract
Background: Epilepsy is a common brain disorder characterized by a chronic predisposition to generate
spontaneous seizures. The mechanisms for epilepsy formation remain unknown. A growing body of evidence
suggests the involvement of inflammatory processes in epileptogenesis. In the present study, we investigated the
involvement of monocyte chemoattractant protein-1 (MCP-1) in aberrant migration of hippocampal progenitors in
rats after the insult of status epilepticus (SE).
Methods: SE was induced with pilocarpine in Sprague–Dawley rats. Transcriptional expression of MCP-1 in the
dentate gyrus (DG) was measured using quantitative real-time PCR. From 1 to 28 days after SE, the temporal
profiles of MCP-1 protein expression in DG were evaluated using enzyme-linked immunosorbent assay. Chemokine
(C-C motif) receptor 2 (CCR2) expression in doublecortin-positive neuronal progenitors was examined using
double-labeling immunohistochemistry. The involvement of MCP-1/CCR2 signaling in aberrant neuronal progenitor
migration in the epileptic hippocampus was assessed in the SE rats using a CCR2 antagonist, RS102895, and the
ectopic migration of neuronal progenitors was determined using Prox1/doublecortin double immunostaining.
Results: After SE, MCP-1 gene was significantly upregulated and its corresponding protein expression in the DG
was significantly increased on days 1 and 3. Some hilar ectopic progenitor cells of SE rats expressed the MCP-1
receptor, CCR2. Notably, the ectopic migration of neuronal progenitors into hilus was attenuated by a blockade of
the MCP-1/CCR2 interaction with a selective CCR2 inhibitor, RS102895.
Conclusions: An increase in dentate MCP-1 is associated with seizure-induced aberrant migration of neuronal
progenitors through the interaction with CCR2. The upregulation of MCP-1 after an insult of SE may play a role in
the generation of epilepsy.
Keywords: Chemokine (C-C motif) receptor 2 (CCR2), Dentate gyrus, Epileptogenesis, Monocyte chemoattractant
protein-1 (MCP-1), Neuroinflammation, Neuronal progenitor migration, Pilocarpine-induced status epilepticus, Rats
Background
Mesial temporal lobe epilepsy (MTLE) is a common type
of epilepsy; more than half of patients with MTLE con-
tinue to experience seizures despite intensive medical
treatment [1]. In some MTLE patients, a medical
history-taking reveals an early precipitating brain insult
and a following seizure-free latent period before the
occurrence of unprovoked recurrent seizures in later
childhood or adolescence. Epileptogenic insults may in-
duce molecular and pathophysiological alterations in the
hippocampus, including selective neuronal loss in the
CA1, CA3 and dentate hilus, dentate neurogenesis, syn-
aptic reorganization, gliosis and inflammatory responses
[2-5]. These structural and functional changes in the
hippocampal formation are potentially involved in the
development of MTLE [2,3,6]. According to previous
pathological studies in MTLE, the neuroplastic changes
in the hippocampal dentate gyrus (DG) are important
for local hyperexcitability and subsequent development
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of epilepsy [6]. However, the exact mechanisms under-
lying the epileptogenic structure alterations remain
unclear.
Previous studies in experimental animals and human
patients [5] have suggested a potential contribution of
inflammatory process to seizure-related pathologies and
the induction of epilepsy [7,8]. Seizures may trigger sig-
nificant inflammatory responses, including activation of
glial cells and secretion of inflammatory mediators by
microglia, astrocytes and affected neurons [5]. Patho-
logical alterations in animal models of epilepsy, such as
neuronal cell death, reactive gliosis and neuroplastic
changes, might be associated with these neuroinflamma-
tory responses [9]. Therefore, neuroinflammation may
participate in epileptogenesis [5,7-9].
Several chemokines and chemokine receptors expressed
in normal brain participate in various physiological pro-
cesses, including the regulation of neuronal development
and migration, synaptic activity and cellular communica-
tion [10,11]. These molecules can be up-regulated in
response to inflammatory brain insults [11-13]. The che-
mokine monocyte chemoattractant protein-1 (MCP-1) is
increased in patients with intractable epilepsy, suggesting
its possible involvement in the pathogenesis of epilepsy
[14-16]. In animal studies, MCP-1 expression in the hippo-
campus was up-regulated after acute seizures [17,18].
MCP-1, one of the most commonly expressed chemokines
in the inflamed brain [19], belongs to a member of the
cysteine-cysteine (CC) chemokine gene family. Members
of this gene family attract monocytes and activate T cells
and B cells through their interaction with the seven-
transmembrane domain, G protein-coupled receptors
chemokine (C-C motif) receptor 2 (CCR2) or CCR9 [20].
Elevated MCP-1 expression in the inflamed brain is related
to the activation and recruitment of macrophages/micro-
glia and granulocytes near the site of injury [18] and is also
related to the breakdown of the blood–brain barrier [19,21].
Accordingly, MCP-1 in the epileptic brain might participate
in the inflammation-related epileptogenesis of MTLE.
In addition to involving inflammatory response, MCP-
1 may enhance the migration of adult neural progenitors
in vitro [22,23]. MCP-1 may induce neural progenitor
migration from the subventricular zone toward the
damaged brain regions after focal ischemia, since expres-
sion of MCP-1 receptor CCR2 has been identified in the
migrating neuroblasts [23]. Also, MCP-1 is important in
attracting neural progenitors toward sites of neuroin-
flammation in the hippocampus [13,24]. Thus, MCP-1 is
a potential regulator of neuronal progenitor migration in
response to brain insults [23]. In the epileptic hippocam-
pus, ectopic granule cells derived from newborn neurons
were observed in the dentate hilus following seizure ac-
tivity [25,26]. The aberrant migration of neuronal pro-
genitors may contribute to the formation of epileptic
neuronal circuits and hyperexcitability in the hippocam-
pus [25-27]. In response to these findings, we hypothe-
sized that MCP-1 participates in epileptogenesis through
its attraction of neural progenitors in the subgranular
zone (SGZ) to form hilar ectopic granule cells.
To study the pro-epileptogenic role of MCP-1 in the
seizure-induced aberrant reorganization of the dentate
hilus, we evaluated the temporal profiles of MCP-1 ex-
pression in the DG after pilocarpine-induced status epi-
lepticus (SE) and determined whether MCP-1 enhances




Adult male Sprague–Dawley rats weighing 200 to 350 g
were housed in a controlled environment (lights on from
8:00 A.M. to 8:00 P.M.) and given free access to food
and water. Animal protocols were approved by the
Taipei Veterans General Hospital Institutional Animal
Care and Use Committee (Permit Number: 97–100),
Taipei, Taiwan, and conformed to the National Institutes
of Health (NIH) Guidelines of USA for the care and use
of laboratory animals.
Pilocarpine-induced status epilepticus
In order to assess MCP-1 gene expression profiles of
hippocampal DG in response to a SE insult, pilocarpine
hydrochloride (325 mg/kg; Sigma, St. Louis, MO, USA)
was intraperitoneally (i.p.) administered in 6 rats, while
normal saline of the same volume was i.p. injected in 7
control rats. In a separate experiment for the analysis of
protein and histopathological alterations, rats were pre-
treated with scopolamine methylnitrate (1 mg/kg, i.p.;
Sigma) to reduce peripheral cholinergic side effects [28].
Thirty minutes later, pilocarpine hydrochloride was
given to induce SE. In age-matched control rats, pilocar-
pine was replaced with normal saline. Animal behavior
was monitored, and only the rats exhibiting convulsive
SE at stage 5 of Racine’s scale were enrolled for subse-
quent experimental manipulations [25]. Two hours after
SE onset, rats were treated with diazepam (10 mg/kg,
i.p.; China Chemical & Pharmaceutical Co., Ltd., Taipei,
Taiwan) to terminate seizures.
Administration of RS102895, an antagonist of CCR2b
As a potent and specific antagonist of CCR2b, RS102895
(Tocris Bioscience, Ellisville, MO, USA) can inhibit
MCP-1/CCR2 signaling in rodents [29,30]. One day after
SE induction, SE rats were subcutaneously treated with
10 mg/kg of RS102895 (in a solution of 10% dimethyl
sulfoxide (DMSO; Sigma) and 90% normal saline) for 3
days. Then the dose of RS102895 was 5 mg/kg for subse-
quent days until one day prior to sacrifice.
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Preparation of the DG
Animals were deeply anesthetized via isoflurane inhal-
ation (AErrane, Baxter, Guayama, PR, USA) and decapi-
tated. The brain was quickly removed from the skull and
placed into ice-cold phosphate-buffered saline (PBS).
Hippocampal DG tissue was carefully dissected out from
each cerebral hemisphere by sliding 30-gauge needles
superficially along the boundaries of the DG and
Ammon’s horn within the hippocampus [31]. The left or
right DG was chosen at random for total RNA isolation
and protein extraction.
RNA isolation and quantitative real-time reverse
transcriptase PCR (qRT-PCR)
To obtain hippocampal dentate RNA for qRT-PCR, SE
rats were sacrificed 30 min after diazepam injection.
Total RNA was isolated using TRIzol reagent (Invitro-
gen, Carlsbad, CA, USA) according to the manufac-
turer’s instructions. The integrity of each RNA sample
was confirmed using agarose gel electrophoresis and an
Agilent 2100 Bioanalyzer (Agilent Technologies, Santa
Clara, CA, USA).
qRT-PCR was performed in triplicate to validate the
expression of MCP-1 [32]. First, total RNA was reverse-
transcribed into cDNA. A 20 μL reaction volume con-
taining 2.5 μg of total RNA was used in the first-strand
cDNA synthesis reaction. Oligo dT (0.5 μg) and dNTP
mix (1 μL, 10 mM) were added to total RNA. The mix-
ture was heated to 65°C for 5 min and quickly chilled on
ice for 2 min. Then, 5× first-strand buffer (5 μL), dTT
(1 μL) and SuperScript III reverse transcriptase (1 μL,
200U, Invitrogen) were added to the reverse transcrip-
tion reaction mixture. Following incubation of the
mixture at 42°C for 60 min and then 70°C for 15 min,
first-strand cDNA was generated. Next, qRT-PCR was
carried out using the SYBR Green chemistry for ampli-
con detection on the LightCycler 480 Real-Time PCR
System (Roche Applied Science, Indianapolis, IN, USA).
Each sample for qRT-PCR contained the following: 10
μL 2× FastStart Universal Probe Master (Roche Applied
Science), 1 μL primers for MCP-1 (forward: TGAACTT
GACCCATAAATCTGAAG, reverse: AAGGCATCACA
TTCCAAATCAC) and for GAPDH (forward: CTCCCA
TTCTTCCACCTTTG, reverse: CTTGCTCTCAGTATC
CTTGC), and 1 μL cDNA. The final volume was adjusted
to 20 μL with the addition of H2O. Temperature cycling
was performed as follows: 3 min polymerase activation at
95°C followed by 45 cycles of denaturation at 95°C for 30
sec, annealing at 55°C for 30 sec and extension at 72°C for
30 sec. The fluorescence signal was read during the exten-
sion step of each cycle. To distinguish between the specific
and non-specific products and primer dimers, melting
curves were obtained by ramping the temperature 1°C
every second from 55°C to 95°C after PCR amplification.
The relative fold change of gene expression was calculated
by the value of 2^ΔCT (compared to the control group)
and normalized to the expression of the housekeeping
gene GAPDH.
Detection of MCP-1 protein in the DG by enzyme-linked
immunosorbent assay (ELISA)
DG tissue was dissected at 1, 3, 7, 14 and 28 days after
SE in SE rats (n = 6 per time points) and at 1 day after
saline treatment in control rats (n = 6). Total protein
was extracted using T-PER tissue protein extraction re-
agent (Pierce Biotechnology, Inc., Rockford, IL, USA)
containing EDTA-free Complete protease inhibitors
(Roche Applied Science), according to the manufac-
turer’s recommendations. Total protein concentration
was determined using the Bio-Rad protein assay kit
(Bio-Rad, Hercules, CA, USA). MCP-1 protein concen-
tration from each sample was evaluated using the BD
OptEIA Rat MCP-1 ELISA kit (BD Biosciences Pharmin-
gen, San Diego, CA, USA), according to the manufac-
turer’s instructions, and then normalized to the total
protein content. The data of MCP-1 protein concentra-
tion were presented as pg/μg of total protein.
Tissue preparation and immunohistochemistry
Rats were deeply anesthetized with Zoletil 50 anesthesia
(10 mg/kg, i.p.; Virbac Laboratories, Carros, France) and
perfused transcardially with ice-cold normal saline, followed
by 4% paraformaldehyde in PBS (10 mM, pH 7.4). Brain tis-
sue was removed immediately after perfusion, post-fixed in
4% paraformaldehyde overnight at 4°C and cryoprotected
with 30% (w/v) sucrose in PBS. Coronal sections (40 μm)
through the dorsal hippocampus (AP = −1.8 to −6.12 mm)
were prepared using a freezing microtome (CM1900, Leica,
Heidelberg, Germany) and stored in an antifreeze solution
(50 mM phosphate buffer, 15% glucose, 30% (v/v) ethylene
glycol, 0.05% sodium azide; pH 7.4) at −20°C until further
testing [33]. Every 12th section (480 μm apart) through the
hippocampus was selected in each rat.
To detect the expression patterns of MCP-1 and pros-
pero homeobox protein 1 (Prox1), free-floating tissue
sections were incubated in 3% H2O2 for 30 min to block
endogenous peroxidase. After a PBS rinse for 10 min,
sections were placed in 3% NHS at room temperature
(RT) for 30 min. The sections were then incubated over-
night at 4°C with goat polyclonal MCP-1 primary anti-
body (1:100; sc-1785, Santa Cruz Biotechnology, Santa
Cruz, CA, USA) and rabbit polyclonal Prox1 primary
antibody (1:2000; ab5475, Millipore, Temecula, CA,
USA). Sections were then washed and incubated for 1 hr
at RT in biotinylated-secondary anti-goat antibody
(1:300; Vector Laboratories, Burlingame, CA, USA) and
anti-rabbit antibody (1:300; Vector Laboratories), re-
spectively. After washing three times, the sections were
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incubated in the avidin-biotin complex (Vector Labora-
tories) for 30 min. The sections were then washed three
times and reacted with diaminobenzidine tetrahy-
drochloride (DAB; Sigma) (in 1.5% NaCl containing
0.015% hydrogen peroxide) for 5 min. The color reaction
was stopped with ice-cold PBS.
To characterize the cellular source of MCP-1, tissue
sections were blocked in 3% normal horse serum (NHS)
(in 0.1 M Tris, 0.1% Triton X-100) for 30 min at RT and
then incubated overnight at 4°C with a goat polyclonal
MCP-1 primary antibody (1:100; sc-1785, Santa Cruz
Biotechnology). Following primary antibody treatment,
sections were washed in PBS, incubated with DyLight
594-conjugated secondary anti-goat antibody (1:500;
Jackson ImmunoResearch Laboratories, West Grove,
PA, USA) for 1 hr at RT, washed in PBS and incubated
in mouse monoclonal primary antibodies as follows:
CD11b antibody (1:100; ab1211, Abcam, Cambridge,
MA, USA), neuronal neuclei protein (NeuN) antibody
(1:500; MAB377, Millipore), and glial fibrillary acidic
protein (GFAP) antibody (1:1000; MAB360, Millipore) at
4°C overnight. After washing in PBS, sections were incu-
bated in DyLight 488-conjugated secondary anti-mouse
antibody (1:500; Jackson ImmunoResearch Laboratories)
for 1 hr at RT and then washed in PBS.
To determine whether neuronal progenitors in DG ex-
press MCP-1 receptor CCR2, immunofluorescent double
staining was performed. The tissue sections were first
blocked in 3% NHS for 30 min at RT and then incubated
with rabbit polyclonal CCR2 antibody (1:100; ab21667,
Abcam) for 48 hr at 4°C. Following primary antibody treat-
ment, sections were washed in PBS, incubated with
DyLight 488-conjugated secondary anti-rabbit antibody
(1:500; Jackson ImmunoResearch Laboratories) for 1 hr at
RT, and washed in PBS. Negative controls for CCR2 im-
munochemistry were performed by blocking with the
CCR2 peptide (ab22407, Abcam) that was used as an
immunogen for the CCR2 antibody production and also by
omitting the primary CCR2 antibody. The tissue sections
were then incubated with a goat polyclonal doublecortin
(Dcx) antibody (1:100; sc-8066, Santa Cruz Biotechnology)
for 48 hr at 4°C. After washing in PBS, sections were
incubated in DyLight 594-conjugated secondary anti-goat
antibody (1:500; Jackson ImmunoResearch Laboratories)
for 1 hr at RT and then washed in PBS.
Double-immunofluorescence labeling for Prox1 and
CCR2 was performed using 1:200 mouse monoclonal
Prox1 antibody (MAB5652, Millipore) and 1:500 DyLight
549-conjugated secondary anti-mouse antibody (Jackson
ImmunoResearch Laboratories), followed by rabbit poly-
clonal CCR2 antibody (1:100; ab21667, Abcam) and
DyLight 488-conjugated secondary anti-rabbit antibody
(1:500; Jackson ImmunoResearch Laboratories). To ensure
that the hilar ectopic Prox1-expressing cells are neuronal
progenitors, double-immunofluorescence staining for
Prox1 and Dcx was performed. The sections were incu-
bated in a rabbit polyclonal Prox1 antibody (1:1000;
ab5475, Millipore) and DyLight 488 -conjugated secondary
anti-rabbit antibody (1:500; Jackson ImmunoResearch
Laboratories), followed by a goat polyclonal Dcx antibody
(1:100; sc-8066, Santa Cruz Biotechnology) and DyLight
594-conjugated secondary anti-goat antibody (1:500;
Jackson ImmunoResearch Laboratories).
All of the tissue sections were then mounted on
gelatin-coated slides and air-dried. The sections for
immunoperoxidase staining were coverslipped with DPX
Mountant (Fluka, Buchs, Switzerland), and those for im-
munofluorescent staining were coverslipped with Vecta-
shield HardSet mounting medium with DAPI (H-1500;
Vector Laboratories). Immunoperoxidase-stained sec-
tions were detected using a bright-field microscope
(Olympus BX61, Olympus Optical Co. Ltd.) and photo-
micrographs were captured using a digital camera
(Olympus CC12, Olympus Optical Co. Ltd.) with a 10×
objective.
To confirm the types of MCP-1 expressing cells, fluor-
escent images were detected using an epi-fluorescent
microscope (Olympus BX61, Olympus Optical Co. Ltd.)
Figure 1 Schematic illustration of the stereological methods for
quantification of Prox1/Dcx-positive cells in hilus. The upper
panel represents the tracing procedure for the contour of the hilar
region. Some 50 μm diameter circles were placed on the interior of
the granule cell layer to exclude the SGZ. The boundaries of hilus
was traced along the edge of the circles in hilus, from the vertex of
the granule cell layer to a straight line drawn between the two
lateral tips of the granule cell layer. The lower panel demonstrates a
counting frame of 50×50 μm distributed in a randomly oriented
150×150 μm XY grid. Only the grids within the traced contour were
included. GCL: granule cell layer; H: hilus.
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and photomicrographs were captured using a digital
camera (Olympus CC12, Olympus Optical Co. Ltd.) with
a 10× objective. In addition, the hilar ectopic Dcx/
CCR2-expressing neuroblasts, Prox1/CCR2-expressing
cells and Prox1/Dcx-expressing progenitors, were veri-
fied by a laser scanning confocal microscope (Olympus
FV1000, Olympus Optical Co. Ltd.) with 20× and 60×
objectives.
Stereology of Prox1/Dcx double-labeled cells
The number of Prox1/Dcx-positive cells in the bilateral
dentate hilus was estimated in every 12th section using
the optical fractionator [34] with StereoInvestigator 9
software (Microbrightfield, Williston, VT, USA). The
sections were viewed in an epi-fluorescent microscope
(Olympus BX51, Olympus Optical Co. Ltd.) with a
motorized stage. The contours around regions of interest
were traced with a 10× objective and the Prox1/Dcx
double-labeled cells were counted with a 40× objective.
The hilus was demarcated by the border of the upper
and lower blades of the granule cell layer, and a straight
line drawn between the two lateral tips of granule cell
layer. Because it was difficult to determine the border
between CA3c and hilus in Prox1/Dcx immunostained
sections, the immunoreactive cells in CA3c were
included in this study.
Figure 2 Upregulated MCP-1 expression in the DG after SE. (A) Mean fold-change (+ SEM) of MCP-1 gene expression in SE rats with respect to
control rats. *P <0.05 compared with the control group. (B) Mean concentration (+ SEM) of MCP-1 protein at 1 to 28 days after SE. *P <0.05, ***P <0.001
compared with the control group. (C) Distribution patterns in the DG of MCP-1 expression (left upper panel) and its co-labeling with CD11b (right
upper panel), NeuN (left lower panel) and GFAP (right lower panel) on day 1 after SE. Arrowheads denote MCP-1-positive cells in hilus. Arrows denote
MCP-1-positive cells (red) co-labeled with CD11b, GFAP and NeuN (green), respectively. Scale bar: 100 μm. GCL: granule cell layer; H: hilus.
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To exclude the Prox1/Dcx-positive cells at the border
of the granule cell layer and hilus, 50 μm diameter cir-
cles were placed on the interior of the granule cell layer
and the contour of the hilus was traced along the edge
of these circles in hilus, from the vertex of the granule
cell layer to a straight line drawn between the two lateral
tips of granule cell layer [35]. Within the contour of the
hilus, a counting frame of 50×50 μm was distributed in
a randomly oriented 150×150 μm XY grid (Figure 1).
The Prox1/Dcx double-labeled cells at each counting
frame were counted within the optical dissector height
(20 μm) centered between top and bottom guard zones
(5 μm) to estimate the number of hilar ectopic neur-
onal progenitors. In each section, the cell count and
total volume of traced hilar region were estimated
according to the formula developed by West et al.
[34,36] and Cavalieri’s principle [37], as described pre-
viously [35,38]. The data were expressed as the num-
ber of Prox1/Dcx-positive cell per unit volume of the
hilus (cells/mm3 + SEM).
Figure 3 Confocal micrographs of MCP-1 receptor, CCR2 and Dcx in the hippocampal DG. (A) As shown in top panels, CCR2-positive cells
(green) appeared in the GCL, SGZ and hilus. Within the SGZ, CCR2-positive cells were double-labeled with a neuroblast marker Dcx (red). Note that
Dcx-positive cells appeared ectopically within the hilus after SE, and a subset of these cells expressed CCR2. The middle and bottom panels show
projected z-stack confocal images to demonstrate colocalization of CCR2 with Dcx. White brackets mark the magnified views of the area. Arrows
denote CCR2/Dcx-positive cells. The cell denoted by the asterisk is enlarged to illustrate the pattern of CCR2 and Dcx labeling. Scale bar: top and
middle, 50 μm; bottom, 10 μm. GCL: granule cell layer; H: hilus; SGZ: subgranular zone. (B) Negative control immunostaining images for CCR2 when
the CCR2 primary antibody was omitted (right) or eliminated by a blocking peptide (left). Neuclei were counterstained with DAPI (blue).
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Statistical analysis
The qRT-PCR data were statistically analyzed by
independent-samples t-test. MCP-1 protein concentrations
in the DG at the indicated time points in the SE groups
were compared with those in the control group using one-
way ANOVA followed by Dunnett’s post hoc test. The dens-
ity of hilar ectopic Prox1/Dcx-positive cells in all groups
was statistically analyzed using one-way ANOVA followed
by the Scheffe post hoc test. The data were shown as the
mean + SEM. The significance level was set at P <0.05.
Results
MCP-1 expression in the hippocampal DG after SE
There was a significant increase in MCP-1 gene expres-
sion in response to seizure insults compared with the
control (P = 0.022; independent-samples t-test; n = 6 to
7 rats per group) (Figure 2A). Compared with the
control levels, MCP-1 protein expression in the DG was
significantly increased one day (P = 0.000052) and three
days (P = 0.013) post-SE (one-way ANOVA, F(df = 5,
30) = 8.17, P = 0.000058, Dunnett’s post hoc test; n = 6
rats per time point) (Figure 2B). Double-labeling immu-
nohistochemical analysis at one day after SE showed that
MCP-1 expression was mainly found in CD11b-positive
reactive microglia within the hilar area and that some
MCP-1 expressing cells were co-labeled with GFAP and
NeuN (Figure 2C).
Distribution of MCP-1 receptor CCR2 in the hippocampal
DG after SE
In the DG, CCR2-positive cells were found in the hilus, the
SGZ and the granule cell layer. In the SGZ, CCR2-expressing
cells were double-labeled with Dcx in control and SE rats, in-
dicating that neural progenitors express CCR2. Furthermore,
Figure 4 Effects of MCP-1/CCR2 inhibition on the formation of hilar-ectopic granule cells. (A) Granule cells were immunolabeled with the
granule cell-specific marker Prox1 in controls, vehicle-treated SE rats, and RS102895-treated SE rats. In SE rats, Prox1 expression was observed not
only in the granule cell layer but also in the hilus. Note that the number of Prox1-expressing cells in the hilus was reduced in the SE rats treated
with RS102895. Arrows denote the Prox1-positive cells. Scale bar: 200 μm. (B) Confocal micrographs for Prox-1 (red) and CCR2 (green) showing a
co-expression of CCR2 in Prox-1-expressing cells in the hilus at 14 days post-SE. The middle and bottom panels show projected z-stack confocal
images to demonstrate colocalization of Prox1 with CCR2, as denoted by arrows. White brackets mark the magnified views of the area. Scale bar:
top and middle, 50 μm; bottom, 10 μm. GCL: granule cell layer; H: hilus.
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we also found the ectopically located Dcx-positive cells in the
hilar region of SE rats, and a subset of these cells also
expressed CCR2 (Figure 3A). CCR2 immunostaining was
abolished either by pretreatment with a synthetic immuno-
genic peptide or by omitting the primary antibody (Figure 3B).
Effect of a CCR2 antagonist RS102895 on the ectopic
migration of neuronal progenitors after SE
As shown in Figure 4A, Prox1 expression in the controls
was found throughout the granule cell layer. In the SE
rats, Prox1-expressing cells in the hilus at 14 days post-
SE also expressed CCR2 (Figure 4B). According to
double-immunofluorescence staining for Prox1 and Dcx,
Prox1/Dcx-expressing neuronal progenitors were found
primarily within the SGZ in controls. In SE rats, the
number of Prox1/Dcx-expressing neuronal progenitors
in the hilus was decreased after administration of a
CCR2 antagonist RS102895 (Figure 5).
Quantitative stereological analysis further confirmed
that the density of Prox1/Dcx-expressing neuronal
progenitors in the hilus was significantly higher in the
SE rats treated with vehicle compared with control
rats (P = 0.0001; one-way ANOVA, F(df = 2, 9), P =
0.00010, Scheffe post hoc test; n = 5 sections per rat,
4 rats per group) and the SE rats treated with
RS102895 (P = 0.018; one-way ANOVA, F(df = 2, 9),
Figure 5 Confocal micrographs of Prox1-expressing progenitors (green) co-labeled with Dcx (red) in the hilus regions of control rats,
vehicle-treated SE rats, and RS102895-treated SE rats on Day 14 after SE. The middle and right panels show projected z-stack confocal
images to demonstrate colocalization of Prox1 with Dcx. Prox1/Dcx-expressing progenitors appeared within the SGZ in control and SE rats. Note
that Prox1/Dcx-expressing progenitors appeared ectopically within the hilus after SE, and the formation of these hilar ectopic neuronal
progenitors was attenuated by administration of RS102895. Arrows denote the Prox1/Dcx-positive cells. White brackets mark the magnified views
of the area. The cell denoted by the asterisk is enlarged to illustrate the pattern of Prox1 and Dcx labeling. Scale bar: left and middle, 50 μm;
right, 10 μm. GCL: granule cell layer; H: hilus; SGZ: subgranular zone.
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P = 0.00010, Scheffe post hoc test; n = 5 sections per
rat, 4 rats per group) (Figure 6). Table 1 shows a
summary of the estimation of Prox1/Dcx-expressing
cell density in the hilus.
Discussion
Following SE, MCP-1 expression was up-regulated in the
DG and CCR2-exhibiting neuroblasts appeared ectopically
in the hilus. Notably, the ectopic migration of neuronal
progenitors into hilus was significantly decreased by inhi-
biting the MCP-1/CCR2 interaction. These findings sug-
gest an important role of MCP-1 in the aberrant
migration of neuronal progenitors after SE.
Abnormalities in DG and epileptogenesis
The pathogenic mechanisms of MTLE remain largely
unknown. As a gating structure in the hippocampal cir-
cuit [6], the DG has been an important target in human
and experimental studies. Mossy fiber sprouting, select-
ive neuron loss and abnormal neurogenesis have been
considered to be histopathological changes contributing
to synaptic reorganization and local hyperexcitability in
the DG [6]. Several recent studies have implicated aber-
rant neurogenesis in the DG in the development of epi-
lepsy. Acute seizure activity promotes the rate of dentate
neurogenesis [4,39,40], and prolonged seizures may
dysregulate the migration of the DG progenitor cells
and lead to hilar-ectopic granule cells [25,26,41,42].
Consistent with previous research, the present study
found ectopic Dcx-positive neuroblasts and Prox1-
positive granule cells in the hilus after SE induction
(Figures 3, 4, 5). These ectopic and pre-existing granule
neurons may integrate abnormally with each other and
contribute to network hyperexcitability [25].
MCP-1 related neuroinflammation in epilepsy
The interaction of MCP-1 and its receptor CCR2 in the
brain can mediate monocyte infiltration and microglial
recruitment [43] and contribute to tissue injury via the
modulation of blood–brain barrier permeability [18,19]
under neuroinflammatory conditions. Increased MCP-1
expression has been detected in rodent brains after acute
seizures [17,18,44] and in pathological brain tissue of
epilepsy patients [14-16]. In the present study, MCP-1
expression in the DG was upregulated significantly by
pilocarpine-induced SE, and this change persisted for at
least 28 days (Figure 2A and B).
Our present study further showed that MCP-1 was
expressed mainly by CD11b-positive reactive microglia
within the hilus after SE. Interestingly, the MCP-1
expressing reactive microglia were localized near the ec-
topic locations of neuroblasts (Figure 2C). In line with
our observation of the linkage between MCP-1 expres-
sion and microglia, one recent study in MCP-1-deficient
mice has demonstrated a reduction in microglial migra-
tion to the site of excitatory neurotransmitter release
and a reduction in excitotoxic neuron loss [43]. Taken
together, reactive microglia might be involved in seizure-
induced dentate MCP-1 upregulation and aberrant
migration of neuronal progenitors. Moreover, MCP-1
expression was increased in neurons and astrocytes in
SE rats of the present study. We have previously pro-
posed that the upregulated MCP-1 expression in various
cell types might participate in the neuroplastic and neu-
roinflammatory alterations following SE [17].
Mechanisms of aberrant migration of neural progenitors
In the present study, Dcx-positive neuroblasts in the SGZ
expressed the MCP-1 receptor, CCR2, in both control and
SE rats, and ectopic Dcx/CCR2-positive cells in the hila
were found exclusively in SE rats (Figure 3). The findings
suggest that MCP-1 upregulation in the DG might be
associated with aberrant migration of neural progenitors.
Furthermore, the attenuating effect of a CCR2 antagonist
(RS102895) on the formation of hilar-ectopic Prox1/Dcx-
positive cells (Figures 5 and 6) suggests an interactive
Table 1 Estimates of Prox1/Dcx-positive cells in the hilus
Control SE-vehicle SE-RS102895









Total area (mm2)a 3.85 ±0.21 3.99 ±0.35 4.00 ±0.18
Mean CEb 0.13 0.08 0.09
CE is coefficient of error.
aValues are mean ± SEM.
bMean CE is calculated as √Mean CE2 [34].
Figure 6 Mean density (+ SEM) of Prox1/Dcx-positive cells in
the dentate hilus of controls and SE rats on day 14 after SE.
The number of Prox1/Dcx-positive cells was decreased in RS102895-
treated SE rats compared with vehicle-treated SE rats. *P <0.05,
**P <0.01, ***P <0.001.
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involvement of both MCP-1 and CCR2 in the ectopic mi-
gration of neural progenitors toward the hilar region.
However, Prox1/Dcx-expressing neuronal progenitors
were still found in the hila of SE rats when CCR2 was
inhibited (Figure 5). The migration of neural progenitors
in SE rats may be related to several factors. For example,
the chemokine stromal cell-derived factor-1α (SDF-1α/
CXCL12) has been reported to regulate the migration of
dentate granule cells [45] and embryonic stem cell-
derived neuronal progenitors through the CXCR4 recep-
tor in the hippocampus [46]. One recent study has
further identified a co-expression of CXCR4 and CCR2
in neurogenic cells of mouse brain [45]. Increased
expression of SDF-1α/CXCL12 following seizures
may influence the migration and/or differentiation of
neural progenitors during embryogenesis and in the
adult hippocampus [46]. Moreover, Reelin has been
reported to modulate neural progenitor migration in
rodent and human hippocampal DG. Loss of Reelin
might contribute to ectopic chain migration and to
aberrant integration of newborn neurons in the epi-
leptic adult hippocampus [41].
Conclusions
In conclusion, the MCP-1/CCR2 chemokine-receptor
interaction may lead to aberrant migration of neuronal
progenitors and subsequently contribute to abnormal
synaptic integration and epileptogenesis. Further studies
are needed to clarify the underlying signaling pathways
of aberrant neuronal progenitor migration affected by
MCP-1 following SE. This study supports the involve-
ment of neuroinflammation in epileptogenesis.
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